Our results suggest that: 1) LOH at 3p21 appears in a small percentage of neuroblastomas, suggesting that a candidate tumor suppressor gene of neuroblastic tumors is not located in this region, and 2) promoter hypermethylation of RASSF1A and CASP8 is frequent in neuroblastomas. The gene discussed is RASSF1; the disease is neuroblastic tumor.